120017
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.6 Breast Cancer (Dove Med Press)
- 4.3 Clin Epidemiol
- 2.6 Cancer Manag Res
- 3.2 Infect Drug Resist
- 4.1 Clin Interv Aging
- 6.1 Drug Des Dev Ther
- 4.1 Int J Chronic Obstr
- 8.7 Int J Nanomed
- 2.5 Int J Women's Health
- 3.2 Neuropsych Dis Treat
- 2.4 OncoTargets Ther
- 2.6 Patient Prefer Adher
- 2.6 Ther Clin Risk Manag
- 3.1 J Pain Res
- 3.5 Diabet Metab Synd Ob
- 4.5 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 2.4 Pharmgenomics Pers Med
- 2.6 Risk Manag Healthc Policy
- 4.6 J Inflamm Res
- 2.3 Int J Gen Med
- 3.9 J Hepatocell Carcinoma
- 3.3 J Asthma Allergy
- 2.5 Clin Cosmet Investig Dermatol
- 3.0 J Multidiscip Healthc
已发表论文
整合蛋白质组学和代谢组学揭示鲍曼不动杆菌黏菌素耐药的多方面机制
Authors Hao L , Yang X, Ullah N , Li Y, Wei S, Wang Q, Zhao Z, Liang Z
Received 31 October 2025
Accepted for publication 22 January 2026
Published 3 February 2026 Volume 2026:19 573066
DOI https://doi.org/10.2147/IDR.S573066
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Hazrat Bilal
Ling Hao,1,2 Xiao Yang,3 Nadeem Ullah,4 Yujun Li,1 Shuquan Wei,1 Qizhi Wang,1 Zhuxiang Zhao,1 Zhike Liang1
1Department of Pulmonary and Critical Care Medicine, Guangzhou First People’s Hospital, South China University of Technology, Guangzhou, People’s Republic of China; 2Institute of Clinical Medicine, Guangzhou First People’s Hospital, South China University of Technology, Guangzhou, People’s Republic of China; 3Department of Laboratory Medicine, Guangzhou First People’s Hospital, South China University of Technology, Guangzhou, People’s Republic of China; 4Department of Clinical Microbiology, Umeå University, Umeå, Sweden
Correspondence: Zhuxiang Zhao, Email zhaozhuxiang@126.com Zhike Liang, Email eylzk@scut.edu.cn
Background: The emergence of colistin-resistant Acinetobacter baumannii, particularly extensively drug-resistant carbapenem-resistant A. baumannii (XDR-CRAB), poses a critical global health threat; however, the molecular mechanisms underlying this resistance remain poorly characterized.
Methods: This study utilized integrated tandem mass tag (TMT)-based proteomics and untargeted metabolomics to compare a representative drug-sensitive (DS) strain, a colistin-sensitive multidrug-resistant (MDR-CRAB) strain, and a colistin-resistant extensively drug-resistant (XDR-CRAB) isolate from a Guangzhou hospital, China, with a primary focus on the molecular features associated with resistance in the XDR isolate.
Results: Proteomic analysis identified 260 differentially expressed proteins (DEPs) across these strains, with 98 strongly linked to the colistin-resistant phenotype. These DEPs were enriched in functions related to polysaccharide and sulfate transport, aromatic compound degradation, and cationic antimicrobial peptide (CAMP) resistance. Upregulation of the lipid A modification system, driven by increased expression of PmrA (4.2-fold), PmrB (2.9-fold), and PmrC (5.5-fold) in the XDR strain compared to the MDR strain, is consistent with this CAMP resistance. Metabolomic analysis identified 747 metabolites, with lipids and lipid-like molecules being the most altered class. The XDR strain exhibited reduced relative abundance of several glycerophospholipids and fatty acids/conjugates, when compared to the MDR strain, indicating cell membrane remodeling. Pathway enrichment analysis further implicated purine, glycerophospholipid, starch/sucrose, and glutathione metabolism in colistin resistance.
Conclusion: Colistin resistance in A. baumannii appears to involve a multifaceted strategy integrating lipid A modification, cell membrane remodeling, and metabolic reprogramming. This study provides a high-resolution molecular blueprint of colistin resistant A. baumannii and generates testable hypotheses to inform future diagnostic and therapeutic strategies against resistant infections.
Keywords: Acinetobacter baumannii, multidrug-resistant, extensively drug-resistant, colistin, carbapenem, quantitative proteomics, untargeted metabolomics, lipid A modification
1Department of Pulmonary and Critical Care Medicine, Guangzhou First People’s Hospital, South China University of Technology, Guangzhou, People’s Republic of China; 2Institute of Clinical Medicine, Guangzhou First People’s Hospital, South China University of Technology, Guangzhou, People’s Republic of China; 3Department of Laboratory Medicine, Guangzhou First People’s Hospital, South China University of Technology, Guangzhou, People’s Republic of China; 4Department of Clinical Microbiology, Umeå University, Umeå, Sweden
Correspondence: Zhuxiang Zhao, Email zhaozhuxiang@126.com Zhike Liang, Email eylzk@scut.edu.cn
Background: The emergence of colistin-resistant Acinetobacter baumannii, particularly extensively drug-resistant carbapenem-resistant A. baumannii (XDR-CRAB), poses a critical global health threat; however, the molecular mechanisms underlying this resistance remain poorly characterized.
Methods: This study utilized integrated tandem mass tag (TMT)-based proteomics and untargeted metabolomics to compare a representative drug-sensitive (DS) strain, a colistin-sensitive multidrug-resistant (MDR-CRAB) strain, and a colistin-resistant extensively drug-resistant (XDR-CRAB) isolate from a Guangzhou hospital, China, with a primary focus on the molecular features associated with resistance in the XDR isolate.
Results: Proteomic analysis identified 260 differentially expressed proteins (DEPs) across these strains, with 98 strongly linked to the colistin-resistant phenotype. These DEPs were enriched in functions related to polysaccharide and sulfate transport, aromatic compound degradation, and cationic antimicrobial peptide (CAMP) resistance. Upregulation of the lipid A modification system, driven by increased expression of PmrA (4.2-fold), PmrB (2.9-fold), and PmrC (5.5-fold) in the XDR strain compared to the MDR strain, is consistent with this CAMP resistance. Metabolomic analysis identified 747 metabolites, with lipids and lipid-like molecules being the most altered class. The XDR strain exhibited reduced relative abundance of several glycerophospholipids and fatty acids/conjugates, when compared to the MDR strain, indicating cell membrane remodeling. Pathway enrichment analysis further implicated purine, glycerophospholipid, starch/sucrose, and glutathione metabolism in colistin resistance.
Conclusion: Colistin resistance in A. baumannii appears to involve a multifaceted strategy integrating lipid A modification, cell membrane remodeling, and metabolic reprogramming. This study provides a high-resolution molecular blueprint of colistin resistant A. baumannii and generates testable hypotheses to inform future diagnostic and therapeutic strategies against resistant infections.
Keywords: Acinetobacter baumannii, multidrug-resistant, extensively drug-resistant, colistin, carbapenem, quantitative proteomics, untargeted metabolomics, lipid A modification